AbbVie sued the U.S. Department of Health and Human Services on Wednesday, challenging a decision by the Centers for Medicare & Medicaid Services to impose price controls for Botox. In a complaint ...

Botox is everywhere right now. It’s nearly impossible to walk down a city block or through a suburban strip mall without seeing signs in med spas or even hair salon windows advertising it—sometimes at ...

Add Yahoo as a preferred source to see more of our stories on Google. President Donald Trump and the Centers for Medicare & Medicaid Services (CMS) recently announced the 15 drugs whose prices they ...

AbbVie has sued the Department of Health and Human Services (HHS), challenging the agency’s decision to select its blockbuster anti-wrinkle therapy Botox for the next round of Medicare price ...

Fifteen prescription medications, including Botox and the diabetes drug Trulicity, will be the focus of federal price negotiations that could lower prices for Medicare patients. An outgrowth of the ...

Add Yahoo as a preferred source to see more of our stories on Google. Gloved hand holding a syringe. (Catherine Falls Commercial) The Trump administration on Tuesday announced the next round of ...

With a new cosmetic dermal filler that works twice as long as AbbVie’s Botox, Nashville, Tennessee, company Revance thought it could capture what it termed the “prestige market.” That, of course, came ...